Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guidelines for evaluating new antimicrobial agents.

D N Gilbert1

  • 1Chiles Research Institute, Providence Medical Center, Portland, Oregon 97213.

The Journal of Infectious Diseases
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Panel discussion: morning session.

Bulletin of the New York Academy of Medicine·2009
Same author

Study of different off-line sample processing procedures and the measurement of antibiotic and antiviral levels in human serum by high-performance liquid chromatography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2002
Same author

Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.

Antimicrobial agents and chemotherapy·2001
Same author

A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate.

The American journal of medicine·1998
Same author

Influence of assay methodology on the measurement of free serum ceftriaxone concentrations.

Antimicrobial agents and chemotherapy·1998
Same author

Outpatient parenteral antimicrobial-drug therapy.

The New England journal of medicine·1997
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026
Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026
Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
See all related articles

Updating antimicrobial drug evaluation guidelines is crucial. The Infectious Diseases Society of America (IDSA) should collaborate with the Food and Drug Administration (FDA) to modernize outdated 1977 clinical trial requirements for better infectious disease treatment.

Area of Science:

  • Pharmacology and Drug Evaluation
  • Infectious Diseases
  • Regulatory Science

Background:

  • Current antimicrobial agent evaluation relies on 1977 Food and Drug Administration (FDA) guidelines.
  • Clinical practices and trial designs for anti-infective agents have evolved significantly since 1977.
  • Existing guidelines present inconsistencies with contemporary infectious disease treatment approaches.

Purpose of the Study:

  • To propose modernization of the 1977 FDA clinical trial guidelines for antimicrobial agents.
  • To advocate for a formal collaboration between the Infectious Diseases Society of America (IDSA) and the FDA.
  • To enhance the efficiency and relevance of drug evaluation processes.

Main Methods:

  • Review of existing FDA guidelines from 1977.

Related Experiment Videos

  • Analysis of changes in clinical application of anti-infective agents.
  • Assessment of evolving clinical trial design methodologies.
  • Proposal for a collaborative working relationship between IDSA and FDA.

    • Main Results:

    • The 1977 guidelines contain principles that are no longer fully consistent with current medical practice.
    • The IDSA possesses the expertise to contribute to guideline revision.
    • Industry involvement is considered beneficial for the process.

    Conclusions:

    • Modernizing FDA guidelines is essential for effective antimicrobial drug evaluation.
    • A collaborative effort between IDSA and FDA can lead to updated, relevant guidelines.
    • Improved guidelines will ensure public protection and align with modern infectious disease management.